HER-2 Protein Vaccine in Treating Women With Breast Cancer

NCT00068614 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: HER-2/neu peptide vaccine

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]